共 50 条
- [33] The Mechanism of Kidney Disease Due to APOL1 Risk Variants JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (11): : 2502 - 2505
- [34] APOL1 risk variants drive kidney disease in mice Nature Reviews Nephrology, 2017, 13 : 259 - 259
- [35] Small Molecule APOL1 Inhibitors Block APOL1 Pore Function and Reduce Proteinuria in an APOL1-Mediated Kidney Disease Mouse Model JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 419 - 419
- [36] New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease KIDNEY INTERNATIONAL REPORTS, 2019, 4 (07): : 908 - 910
- [38] Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (11): : 969 - 979
- [39] APOL1 Kidney Disease Discovery to Targeted Therapy in 10 Years CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (01): : 126 - 128
- [40] APOL1 variants and kidney disease in people of recent African ancestry Nature Reviews Nephrology, 2013, 9 : 240 - 244